Developing a Drug for Fatty Liver Disease

This chapter discusses the development and expectations for a drug by Magical Pharmaceuticals to treat fatty liver disease. It explores the challenges of launching the drug and the relationship between fatty liver drugs and obesity drugs. They also mention an upcoming phase three readout for a heart medicine by El Nylem Pharmaceuticals.